Delivery Order SPE2DB22D3301-SPE2DB25FY3VD
- Not listed
- The Defense Logistics Agency (DLA) awarded a $17,899.20 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits, with an ultimate completion date of July 22, 2025. This non-competitive delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The product will be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,201.87 for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of September 4, 2025. This is a firm fixed price delivery order under a non-set-aside competitive procurement. The contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $15,090.63 to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits, with a firm fixed price structure and no set-aside designation. The award was executed on July 21, 2025, with an ultimate completion date of July 22, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. Lupron Depot is a hormone treatment used in medical applications, and this delivery order represents a specific...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,913.40 for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of July 29, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single pharmaceutical delivery under AmerisourceBergen's broader federal medical supply portfolio. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Lupron Depot 3.75 mg kits, valued at $15,025.58 under a firm fixed-price contract type. The order, which has an ultimate completion date of July 29, 2025, represents a non-set-aside award and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $8,949.64 to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of July 15, 2025. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing...
- The Defense Logistics Agency awarded a delivery order valued at $1,491.62 to AmerisourceBergen Drug Corp on September 18, 2025, for the supply of Lupron Depot 3.75 mg kits. This is a firm fixed-price delivery order with no set-aside designation, utilizing competitive procurement procedures. The place of performance is located in Conshohocken, Pennsylvania, with an ultimate completion date of September 19, 2025. As a child contract, this delivery order falls under AmerisourceBergen's larger...
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $17,212.04 by the Defense Logistics Agency (DLA) on August 8, 2025, for the supply of Lupron Depot 3.75 mg kits. The contract is a firm fixed price delivery order with no set-aside designation, indicating competitive award. Performance will be fulfilled from the contractor's location in Conshohocken, Pennsylvania, with an ultimate completion date of August 11, 2025. This delivery order is issued under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order valued at $2,743.72 to AmerisourceBergen Drug Corp for Lupron Depot 45 mg 6-month kits on August 13, 2025, with an ultimate completion date of August 14, 2025. This non-set-aside contract utilizes firm fixed pricing and represents a child order under AmerisourceBergen's larger indefinite delivery contract vehicle with DLA Troop Support Medical. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Lupron Depot 11.25 mg three-month kits, valued at $34,676.08. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by May 1, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB25FY3VDDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,009.28 to AmerisourceBergen Drug Corp for Lupron Depot 3.75 mg kits, with a completion date of April 25, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a single delivery order under AmerisourceBergen's larger pharmaceutical supply framework with DLA. The product will be delivered to the company's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's substantial Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime indefinite delivery vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of medications and medical supplies to support military healthcare programs worldwide. Lupron Depot, a hormone treatment medication, aligns with the company's extensive portfolio of specialty pharmaceuticals delivered through this vehicle to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.0k | 4/24/25 |